Global Healthcare & Medical Market

Healthcare & Medical Comprehensive Study by Type (Pharmaceuticals, Medical devices, Equipment, Consumables.), Technology (Electronic Health Records (EHRs), Telemedicine, Medical Software, Health Apps.) Players and Region - Global Market Outlook to 2032

Healthcare & Medical Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Healthcare & Medical
The healthcare and medical industries cover a wide array of services, products, and technologies designed to enhance and sustain human health. This sector includes hospitals, clinics, pharmaceutical firms, medical device manufacturers, and healthcare providers, all collaborating to offer essential services and treatments. At the heart of healthcare is the prevention, diagnosis, and treatment of illnesses and injuries, utilizing various medical technologies, therapies, and medications. Medical equipment, including diagnostic machines, surgical tools, and patient monitoring systems, is essential in contemporary healthcare. Innovations in medical devices, like wearable health trackers and robotic-assisted surgeries, have transformed patient care, leading to better outcomes and greater precision in treatments. The pharmaceutical industry plays a crucial role as well, with companies engaged in researching, developing, and producing medications that manage diseases, enhance quality of life, and sometimes provide cures. Healthcare also encompasses more than just physical treatment; it includes mental health support, rehabilitation services, and palliative care.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

UnitedHealth Group (Minneapolis, Minnesota, USA), CVS Health (Woonsocket, Rhode Island, USA), McKesson Corporation (Irving, Texas, USA), Cigna (Bloomfield, Connecticut, USA), AbbVie (North Chicago, Illinois, USA), Johnson & Johnson (New Brunswick, New Jersey, USA), Pfizer (New York City, New York, USA), Eli Lilly and Company (Indianapolis, Indiana, USA), Medtronic (Dublin, Ireland), Roche (Basel, Switzerland), Bristol Myers Squibb (New York City, New York, USA), Abbott Laboratories (Abbott Park, Illinois, USA), Gilead Sciences (Foster City, California, USA), Thermo Fisher Scientific (Waltham, Massachusetts, USA) and Aetna (part of CVS Health) (Hartford, Connecticut, USA) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Healthcare & Medical market by Type (Pharmaceuticals, Medical devices, Equipment and Consumables.) and Region.



On the basis of geography, the market of Healthcare & Medical has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Electronic Health Records (EHRs) will boost the Healthcare & Medical market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.



About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Pharmaceuticals
  • Medical devices
  • Equipment
  • Consumables.
By Technology
  • Electronic Health Records (EHRs)
  • Telemedicine
  • Medical Software
  • Health Apps.

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Factor Analysis
    • 3.1. Porters Five Forces
    • 3.2. Supply/Value Chain
    • 3.3. PESTEL analysis
    • 3.4. Market Entropy
    • 3.5. Patent/Trademark Analysis
  • 4. Global Healthcare & Medical, by Type, Technology and Region (value) (2019-2024)
    • 4.1. Introduction
    • 4.2. Global Healthcare & Medical (Value)
      • 4.2.1. Global Healthcare & Medical by: Type (Value)
        • 4.2.1.1. Pharmaceuticals
        • 4.2.1.2. Medical devices
        • 4.2.1.3. Equipment
        • 4.2.1.4. Consumables.
      • 4.2.2. Global Healthcare & Medical by: Technology (Value)
        • 4.2.2.1. Electronic Health Records (EHRs)
        • 4.2.2.2. Telemedicine
        • 4.2.2.3. Medical Software
        • 4.2.2.4. Health Apps.
      • 4.2.3. Global Healthcare & Medical Region
        • 4.2.3.1. South America
          • 4.2.3.1.1. Brazil
          • 4.2.3.1.2. Argentina
          • 4.2.3.1.3. Rest of South America
        • 4.2.3.2. Asia Pacific
          • 4.2.3.2.1. China
          • 4.2.3.2.2. Japan
          • 4.2.3.2.3. India
          • 4.2.3.2.4. South Korea
          • 4.2.3.2.5. Taiwan
          • 4.2.3.2.6. Australia
          • 4.2.3.2.7. Rest of Asia-Pacific
        • 4.2.3.3. Europe
          • 4.2.3.3.1. Germany
          • 4.2.3.3.2. France
          • 4.2.3.3.3. Italy
          • 4.2.3.3.4. United Kingdom
          • 4.2.3.3.5. Netherlands
          • 4.2.3.3.6. Rest of Europe
        • 4.2.3.4. MEA
          • 4.2.3.4.1. Middle East
          • 4.2.3.4.2. Africa
        • 4.2.3.5. North America
          • 4.2.3.5.1. United States
          • 4.2.3.5.2. Canada
          • 4.2.3.5.3. Mexico
  • 5. Healthcare & Medical: Manufacturers/Players Analysis
    • 5.1. Competitive Landscape
      • 5.1.1. Market Share Analysis
        • 5.1.1.1. Top 3
        • 5.1.1.2. Top 5
    • 5.2. Peer Group Analysis (2024)
    • 5.3. BCG Matrix
    • 5.4. Company Profile
      • 5.4.1. UnitedHealth Group (Minneapolis, Minnesota, USA)
        • 5.4.1.1. Business Overview
        • 5.4.1.2. Products/Services Offerings
        • 5.4.1.3. Financial Analysis
        • 5.4.1.4. SWOT Analysis
      • 5.4.2. CVS Health (Woonsocket, Rhode Island, USA)
        • 5.4.2.1. Business Overview
        • 5.4.2.2. Products/Services Offerings
        • 5.4.2.3. Financial Analysis
        • 5.4.2.4. SWOT Analysis
      • 5.4.3. McKesson Corporation (Irving, Texas, USA)
        • 5.4.3.1. Business Overview
        • 5.4.3.2. Products/Services Offerings
        • 5.4.3.3. Financial Analysis
        • 5.4.3.4. SWOT Analysis
      • 5.4.4. Cigna (Bloomfield, Connecticut, USA)
        • 5.4.4.1. Business Overview
        • 5.4.4.2. Products/Services Offerings
        • 5.4.4.3. Financial Analysis
        • 5.4.4.4. SWOT Analysis
      • 5.4.5. AbbVie (North Chicago, Illinois, USA)
        • 5.4.5.1. Business Overview
        • 5.4.5.2. Products/Services Offerings
        • 5.4.5.3. Financial Analysis
        • 5.4.5.4. SWOT Analysis
      • 5.4.6. Johnson & Johnson (New Brunswick, New Jersey, USA)
        • 5.4.6.1. Business Overview
        • 5.4.6.2. Products/Services Offerings
        • 5.4.6.3. Financial Analysis
        • 5.4.6.4. SWOT Analysis
      • 5.4.7. Pfizer (New York City, New York, USA)
        • 5.4.7.1. Business Overview
        • 5.4.7.2. Products/Services Offerings
        • 5.4.7.3. Financial Analysis
        • 5.4.7.4. SWOT Analysis
      • 5.4.8. Eli Lilly and Company (Indianapolis, Indiana, USA)
        • 5.4.8.1. Business Overview
        • 5.4.8.2. Products/Services Offerings
        • 5.4.8.3. Financial Analysis
        • 5.4.8.4. SWOT Analysis
      • 5.4.9. Medtronic (Dublin, Ireland)
        • 5.4.9.1. Business Overview
        • 5.4.9.2. Products/Services Offerings
        • 5.4.9.3. Financial Analysis
        • 5.4.9.4. SWOT Analysis
      • 5.4.10. Roche (Basel, Switzerland)
        • 5.4.10.1. Business Overview
        • 5.4.10.2. Products/Services Offerings
        • 5.4.10.3. Financial Analysis
        • 5.4.10.4. SWOT Analysis
      • 5.4.11. Bristol Myers Squibb (New York City, New York, USA)
        • 5.4.11.1. Business Overview
        • 5.4.11.2. Products/Services Offerings
        • 5.4.11.3. Financial Analysis
        • 5.4.11.4. SWOT Analysis
      • 5.4.12. Abbott Laboratories (Abbott Park, Illinois, USA)
        • 5.4.12.1. Business Overview
        • 5.4.12.2. Products/Services Offerings
        • 5.4.12.3. Financial Analysis
        • 5.4.12.4. SWOT Analysis
      • 5.4.13. Gilead Sciences (Foster City, California, USA)
        • 5.4.13.1. Business Overview
        • 5.4.13.2. Products/Services Offerings
        • 5.4.13.3. Financial Analysis
        • 5.4.13.4. SWOT Analysis
      • 5.4.14. Thermo Fisher Scientific (Waltham, Massachusetts, USA)
        • 5.4.14.1. Business Overview
        • 5.4.14.2. Products/Services Offerings
        • 5.4.14.3. Financial Analysis
        • 5.4.14.4. SWOT Analysis
      • 5.4.15. Aetna (part of CVS Health) (Hartford, Connecticut, USA)
        • 5.4.15.1. Business Overview
        • 5.4.15.2. Products/Services Offerings
        • 5.4.15.3. Financial Analysis
        • 5.4.15.4. SWOT Analysis
  • 6. Global Healthcare & Medical Sale, by Type, Technology and Region (value) (2027-2032)
    • 6.1. Introduction
    • 6.2. Global Healthcare & Medical (Value)
      • 6.2.1. Global Healthcare & Medical by: Type (Value)
        • 6.2.1.1. Pharmaceuticals
        • 6.2.1.2. Medical devices
        • 6.2.1.3. Equipment
        • 6.2.1.4. Consumables.
      • 6.2.2. Global Healthcare & Medical by: Technology (Value)
        • 6.2.2.1. Electronic Health Records (EHRs)
        • 6.2.2.2. Telemedicine
        • 6.2.2.3. Medical Software
        • 6.2.2.4. Health Apps.
      • 6.2.3. Global Healthcare & Medical Region
        • 6.2.3.1. South America
          • 6.2.3.1.1. Brazil
          • 6.2.3.1.2. Argentina
          • 6.2.3.1.3. Rest of South America
        • 6.2.3.2. Asia Pacific
          • 6.2.3.2.1. China
          • 6.2.3.2.2. Japan
          • 6.2.3.2.3. India
          • 6.2.3.2.4. South Korea
          • 6.2.3.2.5. Taiwan
          • 6.2.3.2.6. Australia
          • 6.2.3.2.7. Rest of Asia-Pacific
        • 6.2.3.3. Europe
          • 6.2.3.3.1. Germany
          • 6.2.3.3.2. France
          • 6.2.3.3.3. Italy
          • 6.2.3.3.4. United Kingdom
          • 6.2.3.3.5. Netherlands
          • 6.2.3.3.6. Rest of Europe
        • 6.2.3.4. MEA
          • 6.2.3.4.1. Middle East
          • 6.2.3.4.2. Africa
        • 6.2.3.5. North America
          • 6.2.3.5.1. United States
          • 6.2.3.5.2. Canada
          • 6.2.3.5.3. Mexico
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. Healthcare & Medical: by Type(USD Million)
  • Table 2. Healthcare & Medical Pharmaceuticals , by Region USD Million (2019-2024)
  • Table 3. Healthcare & Medical Medical devices , by Region USD Million (2019-2024)
  • Table 4. Healthcare & Medical Equipment , by Region USD Million (2019-2024)
  • Table 5. Healthcare & Medical Consumables. , by Region USD Million (2019-2024)
  • Table 6. Healthcare & Medical: by Technology(USD Million)
  • Table 7. Healthcare & Medical Electronic Health Records (EHRs) , by Region USD Million (2019-2024)
  • Table 8. Healthcare & Medical Telemedicine , by Region USD Million (2019-2024)
  • Table 9. Healthcare & Medical Medical Software , by Region USD Million (2019-2024)
  • Table 10. Healthcare & Medical Health Apps. , by Region USD Million (2019-2024)
  • Table 11. South America Healthcare & Medical, by Country USD Million (2019-2024)
  • Table 12. South America Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 13. South America Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 14. Brazil Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 15. Brazil Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 16. Argentina Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 17. Argentina Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 18. Rest of South America Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 19. Rest of South America Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 20. Asia Pacific Healthcare & Medical, by Country USD Million (2019-2024)
  • Table 21. Asia Pacific Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 22. Asia Pacific Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 23. China Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 24. China Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 25. Japan Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 26. Japan Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 27. India Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 28. India Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 29. South Korea Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 30. South Korea Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 31. Taiwan Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 32. Taiwan Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 33. Australia Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 34. Australia Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 35. Rest of Asia-Pacific Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 36. Rest of Asia-Pacific Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 37. Europe Healthcare & Medical, by Country USD Million (2019-2024)
  • Table 38. Europe Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 39. Europe Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 40. Germany Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 41. Germany Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 42. France Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 43. France Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 44. Italy Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 45. Italy Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 46. United Kingdom Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 47. United Kingdom Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 48. Netherlands Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 49. Netherlands Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 50. Rest of Europe Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 51. Rest of Europe Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 52. MEA Healthcare & Medical, by Country USD Million (2019-2024)
  • Table 53. MEA Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 54. MEA Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 55. Middle East Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 56. Middle East Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 57. Africa Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 58. Africa Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 59. North America Healthcare & Medical, by Country USD Million (2019-2024)
  • Table 60. North America Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 61. North America Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 62. United States Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 63. United States Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 64. Canada Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 65. Canada Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 66. Mexico Healthcare & Medical, by Type USD Million (2019-2024)
  • Table 67. Mexico Healthcare & Medical, by Technology USD Million (2019-2024)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Healthcare & Medical: by Type(USD Million)
  • Table 84. Healthcare & Medical Pharmaceuticals , by Region USD Million (2027-2032)
  • Table 85. Healthcare & Medical Medical devices , by Region USD Million (2027-2032)
  • Table 86. Healthcare & Medical Equipment , by Region USD Million (2027-2032)
  • Table 87. Healthcare & Medical Consumables. , by Region USD Million (2027-2032)
  • Table 88. Healthcare & Medical: by Technology(USD Million)
  • Table 89. Healthcare & Medical Electronic Health Records (EHRs) , by Region USD Million (2027-2032)
  • Table 90. Healthcare & Medical Telemedicine , by Region USD Million (2027-2032)
  • Table 91. Healthcare & Medical Medical Software , by Region USD Million (2027-2032)
  • Table 92. Healthcare & Medical Health Apps. , by Region USD Million (2027-2032)
  • Table 93. South America Healthcare & Medical, by Country USD Million (2027-2032)
  • Table 94. South America Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 95. South America Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 96. Brazil Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 97. Brazil Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 98. Argentina Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 99. Argentina Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 100. Rest of South America Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 101. Rest of South America Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 102. Asia Pacific Healthcare & Medical, by Country USD Million (2027-2032)
  • Table 103. Asia Pacific Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 104. Asia Pacific Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 105. China Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 106. China Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 107. Japan Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 108. Japan Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 109. India Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 110. India Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 111. South Korea Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 112. South Korea Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 113. Taiwan Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 114. Taiwan Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 115. Australia Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 116. Australia Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 117. Rest of Asia-Pacific Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 118. Rest of Asia-Pacific Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 119. Europe Healthcare & Medical, by Country USD Million (2027-2032)
  • Table 120. Europe Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 121. Europe Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 122. Germany Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 123. Germany Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 124. France Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 125. France Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 126. Italy Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 127. Italy Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 128. United Kingdom Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 129. United Kingdom Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 130. Netherlands Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 131. Netherlands Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 132. Rest of Europe Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 133. Rest of Europe Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 134. MEA Healthcare & Medical, by Country USD Million (2027-2032)
  • Table 135. MEA Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 136. MEA Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 137. Middle East Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 138. Middle East Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 139. Africa Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 140. Africa Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 141. North America Healthcare & Medical, by Country USD Million (2027-2032)
  • Table 142. North America Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 143. North America Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 144. United States Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 145. United States Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 146. Canada Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 147. Canada Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 148. Mexico Healthcare & Medical, by Type USD Million (2027-2032)
  • Table 149. Mexico Healthcare & Medical, by Technology USD Million (2027-2032)
  • Table 150. Research Programs/Design for This Report
  • Table 151. Key Data Information from Secondary Sources
  • Table 152. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare & Medical: by Type USD Million (2019-2024)
  • Figure 5. Global Healthcare & Medical: by Technology USD Million (2019-2024)
  • Figure 6. South America Healthcare & Medical Share (%), by Country
  • Figure 7. Asia Pacific Healthcare & Medical Share (%), by Country
  • Figure 8. Europe Healthcare & Medical Share (%), by Country
  • Figure 9. MEA Healthcare & Medical Share (%), by Country
  • Figure 10. North America Healthcare & Medical Share (%), by Country
  • Figure 11. Global Healthcare & Medical share by Players 2024 (%)
  • Figure 12. Global Healthcare & Medical share by Players (Top 3) 2024(%)
  • Figure 13. Global Healthcare & Medical share by Players (Top 5) 2024(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. UnitedHealth Group (Minneapolis, Minnesota, USA) Revenue, Net Income and Gross profit
  • Figure 16. UnitedHealth Group (Minneapolis, Minnesota, USA) Revenue: by Geography 2024
  • Figure 17. CVS Health (Woonsocket, Rhode Island, USA) Revenue, Net Income and Gross profit
  • Figure 18. CVS Health (Woonsocket, Rhode Island, USA) Revenue: by Geography 2024
  • Figure 19. McKesson Corporation (Irving, Texas, USA) Revenue, Net Income and Gross profit
  • Figure 20. McKesson Corporation (Irving, Texas, USA) Revenue: by Geography 2024
  • Figure 21. Cigna (Bloomfield, Connecticut, USA) Revenue, Net Income and Gross profit
  • Figure 22. Cigna (Bloomfield, Connecticut, USA) Revenue: by Geography 2024
  • Figure 23. AbbVie (North Chicago, Illinois, USA) Revenue, Net Income and Gross profit
  • Figure 24. AbbVie (North Chicago, Illinois, USA) Revenue: by Geography 2024
  • Figure 25. Johnson & Johnson (New Brunswick, New Jersey, USA) Revenue, Net Income and Gross profit
  • Figure 26. Johnson & Johnson (New Brunswick, New Jersey, USA) Revenue: by Geography 2024
  • Figure 27. Pfizer (New York City, New York, USA) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer (New York City, New York, USA) Revenue: by Geography 2024
  • Figure 29. Eli Lilly and Company (Indianapolis, Indiana, USA) Revenue, Net Income and Gross profit
  • Figure 30. Eli Lilly and Company (Indianapolis, Indiana, USA) Revenue: by Geography 2024
  • Figure 31. Medtronic (Dublin, Ireland) Revenue, Net Income and Gross profit
  • Figure 32. Medtronic (Dublin, Ireland) Revenue: by Geography 2024
  • Figure 33. Roche (Basel, Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Roche (Basel, Switzerland) Revenue: by Geography 2024
  • Figure 35. Bristol Myers Squibb (New York City, New York, USA) Revenue, Net Income and Gross profit
  • Figure 36. Bristol Myers Squibb (New York City, New York, USA) Revenue: by Geography 2024
  • Figure 37. Abbott Laboratories (Abbott Park, Illinois, USA) Revenue, Net Income and Gross profit
  • Figure 38. Abbott Laboratories (Abbott Park, Illinois, USA) Revenue: by Geography 2024
  • Figure 39. Gilead Sciences (Foster City, California, USA) Revenue, Net Income and Gross profit
  • Figure 40. Gilead Sciences (Foster City, California, USA) Revenue: by Geography 2024
  • Figure 41. Thermo Fisher Scientific (Waltham, Massachusetts, USA) Revenue, Net Income and Gross profit
  • Figure 42. Thermo Fisher Scientific (Waltham, Massachusetts, USA) Revenue: by Geography 2024
  • Figure 43. Aetna (part of CVS Health) (Hartford, Connecticut, USA) Revenue, Net Income and Gross profit
  • Figure 44. Aetna (part of CVS Health) (Hartford, Connecticut, USA) Revenue: by Geography 2024
  • Figure 45. Global Healthcare & Medical: by Type USD Million (2027-2032)
  • Figure 46. Global Healthcare & Medical: by Technology USD Million (2027-2032)
  • Figure 47. South America Healthcare & Medical Share (%), by Country
  • Figure 48. Asia Pacific Healthcare & Medical Share (%), by Country
  • Figure 49. Europe Healthcare & Medical Share (%), by Country
  • Figure 50. MEA Healthcare & Medical Share (%), by Country
  • Figure 51. North America Healthcare & Medical Share (%), by Country
List of companies from research coverage that are profiled in the study
  • UnitedHealth Group (Minneapolis, Minnesota, USA)
  • CVS Health (Woonsocket, Rhode Island, USA)
  • McKesson Corporation (Irving, Texas, USA)
  • Cigna (Bloomfield, Connecticut, USA)
  • AbbVie (North Chicago, Illinois, USA)
  • Johnson & Johnson (New Brunswick, New Jersey, USA)
  • Pfizer (New York City, New York, USA)
  • Eli Lilly and Company (Indianapolis, Indiana, USA)
  • Medtronic (Dublin, Ireland)
  • Roche (Basel, Switzerland)
  • Bristol Myers Squibb (New York City, New York, USA)
  • Abbott Laboratories (Abbott Park, Illinois, USA)
  • Gilead Sciences (Foster City, California, USA)
  • Thermo Fisher Scientific (Waltham, Massachusetts, USA)
  • Aetna (part of CVS Health) (Hartford, Connecticut, USA)
Select User Access Type

Key Highlights of Report


Mar 2025 248 Pages 66 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Healthcare & Medical Market Quantitative research analysis
Global Healthcare & Medical Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as UnitedHealth Group (Minneapolis, Minnesota, USA), CVS Health (Woonsocket, Rhode Island, USA), McKesson Corporation (Irving, Texas, USA), Cigna (Bloomfield, Connecticut, USA), AbbVie (North Chicago, Illinois, USA), Johnson & Johnson (New Brunswick, New Jersey, USA), Pfizer (New York City, New York, USA), Eli Lilly and Company (Indianapolis, Indiana, USA), Medtronic (Dublin, Ireland), Roche (Basel, Switzerland), Bristol Myers Squibb (New York City, New York, USA), Abbott Laboratories (Abbott Park, Illinois, USA), Gilead Sciences (Foster City, California, USA), Thermo Fisher Scientific (Waltham, Massachusetts, USA) and Aetna (part of CVS Health) (Hartford, Connecticut, USA) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Healthcare & Medical Market during projected period 2024-2032.
The Healthcare & Medical market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Healthcare & Medical Market Report?

Have a Query? Click Here

Other Related Reports

Big Data And Artificial Intelligence Comprehensive Study by Application (Predictive Analytics & Forecasting, Data Mining & Management, AI-Powered Chatbots & Virtual Assistants, Facial Recognition & B...
$ 3800
Gold- Comprehensive Study by Type (Gold Bullion, Jewelry, Coins, Industrial Gold, Other Forms), Application (Jewellery Fabrication, Technology, Investments, Central Banks), Distribution Channel (Reta...
$ 3800
Beauty and Personal Care- Comprehensive Study by Type (Skincare, Hair Car, Color Cosmetics, Fragrances, Toiletries, Others), Category (Organic Gender, Convectional), Price Range (Premium, Luxury, Bud...
$ 3500
Energy Metering SOC Comprehensive Study by Type (Monophase Type, Triphase Type), Application (Commercial, Residential, Industrial) Players and Region - Global Market Outlook to 2032
$ 3800
Managed Wi Fi Solutions Comprehensive Study by Enterprise Size (Small and Medium Businesses (SMBs), Large Enterprises, Hyper-Scale Enterprises), Solution Type (Cloud-Based Managed Wi-Fi, On-Premises ...
$ 3800
Plastic and Paper Straw Comprehensive Study by Type (Kraft Paper Straws, Printed Paper Straws, Plastic Straws), End User (Hotels, Restaurants & Motels, Bars & Lounges, Cafes, Others), Diameter (<0.15...
$ 3800